SUPERIORSVG 2010.

Trial name or title	Improving the results of heart bypass surgery using new approaches to surgery and medication (SUPERIORSVG)
Methods	RCT
Participants	Adults having coronary artery bypass graft (CABG) using saphenous vein graft (SVG)
Interventions	Each for 12 months: Arm 1: fish oil supplements (2 × 1 g/d Ocean Nutrition capsules: 55% fish oils EPA:DHA 33%:22%) and SVG conventionally harvested Arm 2: placebo and SVG conventionally harvested Arm 3: fish oil supplements (2 × 1 g/d Ocean Nutrition capsules: 55% fish oils EPA:DHA 33%:22%) and SVG no‐touch harvest Arm 4: placebo and SVG no‐touch harvest
Outcomes	Primary: proportion of grafts occluded Secondary: significant stenosis, adverse SVG harvesting events, composite outcome of all‐cause mortality, non‐fatal MI and repeat revascularisation
Starting date	Registered on trials registry: 12 January 2010 Study start date: July 2011 Estimated study completion date: December 2016
Contact information	Stephen Fremes, Sunnybrook Health Sciences Centre (PI)
Notes	NCT01047449